← brief for 2026-10-24 · Slowing decline

Combined and simultaneous use of Nefecon and irbesartan in treatment-naïve primary IgA nephropathy

Article C Peer reviewed Observational

Key takeaways

Twelve people with a specific kidney disease took two drugs together for six months. This small study shows a link between the drug mix and changes in the body, but it is not proof of cause. The group was too small to show if the treatment works for everyone.

Who did this work

Li Tian (Second Hospital of Hebei Medical University) · Huaying Pei (Second Hospital of Hebei Medical University) · Yanpeng Li (Hebei General Hospital) · Wen Xue (Second Hospital of Hebei Medical University) · Ning Lü (Second Hospital of Hebei Medical University) · Xuzhi Liang (Second Hospital of Hebei Medical University) · Shaomei Li (Second Hospital of Hebei Medical University)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-23
https://doi.org/10.1097/md.0000000000051223